Technical Article
Bilayer Gastroretentive Modified-Release Tablets: A Quality-by-Design Approach to Achieving Precise Drug Release and Prolonged Gastric Retention
01 Apr 2026
Join our team in Boston on Saturday for the Chinese Antibody Society 2024 Annual Conference.
Catch up with Crystal Bio's CSO, Billy Wu, Ph.D., and our new CTO, Ye Gu, Ph.D. We will also be joined by Crystal Pharmatech SME, Ridwan Islam, M. Pharm., Ph.D.
Local SMEs and facilities for innovators in Boston. Let's connect!
BD_Global@CrystalPharmatech.com
Subscribe to be the first to get the updates!